A running therapy program rivals antidepressants in treatment of depression and anxiety, research suggests. Running showed greater physical health benefits while adherence is better with medication.
/PRNewswire/ Neurolief, a global medical device company that is delivering life-changing neurotechnology innovations, today announced the appointment of.
Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 trial show.